CENTRICITY RESEARCH Trademark

Trademark Overview


On Friday, December 10, 2021, a trademark application was filed for CENTRICITY RESEARCH with the United States Patent and Trademark Office. The USPTO has given the CENTRICITY RESEARCH trademark a serial number of 97165927. The federal status of this trademark filing is ABANDONED - AFTER EX PARTE APPEAL as of Thursday, February 29, 2024. This trademark is owned by Institute for the Advancement of Clinical Trials, LLC. The CENTRICITY RESEARCH trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Clinical research for healthcare organizations in the field of medicine, the fields of allergy and immunology, cardiology, cardiovascular diseases, critical care, dermatology, emergency medicine, endocrinology, gastroenterology, gerontology, gynecology, hematology, infectious disease, internal medicine, musculoskeletal medicine, neonatology, nephrology, neurology, obstetrics, oncology, ophthalmology, pain management, pediatrics, pharmacology, podiatry, psychiatry, pulmonology, respiratory health, respiratory therapies, rheumatology, surgery, trauma medicine, thoracic surgery, urology, vascular surgery, and women's health; Research and development and consultation related thereto for healthcare organizations in the field of medicine, the fields of allergy and immunology, cardiology, cardiovascular diseases, critical care, dermatology, emergency medicine, endocrinology, gastroenterology, gerontology, gynecology, hematology, infectious disease, internal medicine, musculoskeletal medicine,...
centricity research

General Information


Serial Number97165927
Word MarkCENTRICITY RESEARCH
Filing DateFriday, December 10, 2021
Status603 - ABANDONED - AFTER EX PARTE APPEAL
Status DateThursday, February 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Disclaimer with Predetermined Text"RESEARCH"
Goods and ServicesClinical research for healthcare organizations in the field of medicine, the fields of allergy and immunology, cardiology, cardiovascular diseases, critical care, dermatology, emergency medicine, endocrinology, gastroenterology, gerontology, gynecology, hematology, infectious disease, internal medicine, musculoskeletal medicine, neonatology, nephrology, neurology, obstetrics, oncology, ophthalmology, pain management, pediatrics, pharmacology, podiatry, psychiatry, pulmonology, respiratory health, respiratory therapies, rheumatology, surgery, trauma medicine, thoracic surgery, urology, vascular surgery, and women's health; Research and development and consultation related thereto for healthcare organizations in the field of medicine, the fields of allergy and immunology, cardiology, cardiovascular diseases, critical care, dermatology, emergency medicine, endocrinology, gastroenterology, gerontology, gynecology, hematology, infectious disease, internal medicine, musculoskeletal medicine, neonatology, nephrology, neurology, obstetrics, oncology, ophthalmology, pain management, pediatrics, pharmacology, podiatry, psychiatry, pulmonology, respiratory health, respiratory therapies, rheumatology, surgery, trauma medicine, thoracic surgery, urology, vascular surgery, and women's health; Conducting clinical trials for healthcare organizations in the field of medicine, the fields of allergy and immunology, cardiology, cardiovascular diseases, critical care, dermatology, emergency medicine, endocrinology, gastroenterology, gerontology, gynecology, hematology, infectious disease, internal medicine, musculoskeletal medicine, neonatology, nephrology, neurology, obstetrics, oncology, ophthalmology, pain management, pediatrics, pharmacology, podiatry, psychiatry, pulmonology, respiratory health, respiratory therapies, rheumatology, surgery, trauma medicine, thoracic surgery, urology, vascular surgery, and women's health

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 15, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameInstitute for the Advancement of Clinical Trials, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressColumbus, GA 31904

Trademark Events


Event DateEvent Description
Monday, March 11, 2024ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Thursday, February 29, 2024ABANDONMENT - AFTER EX PARTE APPEAL
Thursday, February 29, 2024EXPARTE APPEAL TERMINATED
Friday, January 19, 2024EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
Tuesday, November 7, 2023NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Tuesday, November 7, 2023ACTION DENYING REQ FOR RECON E-MAILED
Tuesday, November 7, 2023ACTION CONTINUING FINAL - COMPLETED
Thursday, October 5, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, October 5, 2023EX PARTE APPEAL-INSTITUTED
Thursday, October 5, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, October 5, 2023EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, October 3, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 3, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 3, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 3, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 3, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 5, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, July 5, 2023FINAL REFUSAL E-MAILED
Wednesday, July 5, 2023FINAL REFUSAL WRITTEN
Tuesday, March 28, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 27, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 27, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 27, 2022NON-FINAL ACTION E-MAILED
Tuesday, September 27, 2022NON-FINAL ACTION WRITTEN
Monday, September 19, 2022ASSIGNED TO EXAMINER
Wednesday, December 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 14, 2021NEW APPLICATION ENTERED